Humana Q1 GAAP EPS rises to $10.30 from $6.11; cuts GAAP 2025 EPS outlook
Humana reported first-quarter 2025 results with GAAP earnings per share of $10.30, up from $6.11 a year earlier, and revenue of $32.1 billion, up from $29.6 billion. The company lowered its GAAP EPS guidance for 2025 to approximately $14.68 from $15.88, while affirming its adjusted EPS guidance of approximately $16.25.
Key points
- Q1 2025 GAAP EPS was $10.30 versus $6.11 in Q1 2024; adjusted EPS was $11.58 versus $7.23.
- Consolidated revenues were $32,112 million in Q1 2025 versus $29,611 million in Q1 2024.
- FY 2025 GAAP EPS guidance revised to approximately $14.68 from approximately $15.88; adjusted EPS guidance affirmed at approximately $16.25.
- Individual Medicare Advantage membership decline of approximately 550,000 for 2025 was affirmed.
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 30, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.